Which concerns arise when new medications are tested in developing countries?
Low- and middle-income countries are increasingly selected as locations for international clinical trials to tests the safety and efficacy of new drug candidates. But what are the consequences of this development for these countries?
Bastian Rake
Dr. Bastian Rake is Lecturer / Assistant Professor and Director of Strategy and Risk, at Maynooth University School of Business, Ireland.
Learn more about Bastian Rake here: https://www.maynoothuniversity.ie/people/bastian-rake
Area
Society and
economy